Prevention of lung cancer

Critical Reviews in Oncology/Hematology

Volumn 33, Issue 3, 2000, Pages 187-197

  Goodman, Gary E ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BIOLOGICAL MARKER; CAROTENOID; RETINOID; RETINOL PALMITATE; TRACE ELEMENT;

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL TRIAL; HIGH RISK POPULATION; HUMAN; INDUSTRIALIZATION; LUNG CANCER; LUNG CARCINOGENESIS; REVIEW; TOBACCO;

EID: 0034023982     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(99)00074-8     Document Type: Article

References (88)

1. Sporn M.B., Dunlop N.M., Newton D.L. et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 35:1976;1332-1338.
2. Bertram J.S., Kolonel L.N., Meyskens F.L. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 47:1987;3012-3031.
3. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
4. Ziegler R.G., Mayne S.T., Swanson C.A. Nutrition and lung cancer. Cancer Causes Control. 7:1996;157-177.
5. Colditz G.A., Stampfer M.J., Willett W.C. Diet and lung cancer. a review of the epidemiologic evidence in humans. Arch. Intern. Med. 147:1987;157-160.
6. Byers T. Diet as a factor in the etiology and prevention of lung cancer. Samet J.M. Epidemiology of Lung Cancer. 1994;335-352 Marcel Dekker, New York.
7. Block G., Patterson B., Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 18:1992;1-29.
8. Stahelin H.B., Gey K.F., Eichholzer M. et al. Plasma anti-oxidant vitamains and subsequent cancer mortality in the 12-year follow-up of the prospective basel Study. Am. J. Epidemiol. 133:1991;766-775.
9. Nomura A., Heilbrun L.K., Morris J.S. et al. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J. Natl. Cancer Inst. 79:1987;103-108.
10. Wald N.J., Thompson S.G., Densem J.W. et al. Serum Beta-carotene and subsequent risk of cancer: results from the BUPA study. Br. J. Cancer. 57:1988;428-433.
11. Virtamo J., Valkeila E., Alfthan G. et al. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer. 60:1987;145-148.
12. Connett J.E., Kuller L.H., Kjelsberg M.O. et al. Relationship between carotenoids and cancer: the multiple risk factor intervention trial (MRFIT) study. Cancer. 64:1989;126-134.
13. Goodman G.E. Cancer prevention: chemoprevention vs dietary modifications. Prev. Med. 22:1993;1-4.
14. Kelloff G.J., Hawk E.T., Crowell J.A. et al. Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology. 10:1996;1471-1484.
15. Giardiello F.M., Hamilton S.R., Krush A.J. et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl. J. Med. 328:1993;1313-1316.
16. Kelloff G.J., Crowell J.A., Boone C.W. et al. Clinical development plan: piroxicam. J. Cell. Biochem. 20:1994;219-230.
17. Kelloff G.J., Crowell J.A., Boone C.W. et al. Clinical development plan: Sulindac. J. Cell. Biochem. 20:1994;240-251.
18. McCann P.P., Pegg A.E., Sjoeerdsma A. Inhibition of polyamine metabolism: Biological significance and basis for new therapies. 1987;Academic Press, New York.
19. Meyskens F.L. Jr., Emerson S.S., Pelot D. et al. Dose de-escalation chemoprevention trial of a diflouromethylormithine in patients with colon polyps. J. Natl. Cancer. Inst. 86:1994;1122-1130.
20. Kelloff G.J., Crowell J.A., Boone C.W. et al. Clinical development plan: 2-difluoromethylornithine (DFMO). J. Cell. Biochem. 20:1994;147-165.
21. Landis S.H., Murray T., Bolden S. et al. Cancer Statistics. CA: A. Cancer J. for Clinicians. 48:1998;6-29.
22. Garfinkel L., Stellman S.D. Smoking and lung cancer in women: findings in a prospective study. Cancer Res. 48:1988;6951-6955.
23. Strauss G., DeCamp M., Dibiccaro E. et al. Lung cancer diagnosis is being made with increasing frequency in former cigarette smokers! Proc. Am. Soc. Clin. Oncol. 14:1995;362.
24. Shopland D.R., Hartman A.M., Gibson J.T. et al. Cigarette smoking among US adults by state and region: estimates from the current population survey. J. Natl. Cancer Inst. 88:1996;1748-1758.
25. Peto R., Lopez A.L., Boreman J. et al. Mortality from tobacco in developed countries. Indirect estimation from national vital statistics. Lancet. 339:1992;1268-1278.
26. Chollat-Traquet C. Tobacco or health: a WHO programme. Int. J. Cancer. 28:1992;311-315.
27. Gong Y.L., Koplan J.P., Feng W. et al. Cigarette smoking in China: prevalence, characteristics, and attitudes in Minghang district. J. Am. Med. Assoc. 274:1995;1232-1234.
28. Pierce J.P., Choi W.S., Gilpin E.A. et al. Validation of susceptibility as a predictor of which adolescents take up smoking in the United States. Health Psychol. 15:1996;355-361.
29. Gilpin E.A., Pierce J.P., Rosbrook B. Are adolescents receptive to current sales promotion practices of the tobacco industry? Prev. Med. 26:1997;14-21.
30. US Department of Health and Human Services. The health consequences of involuntary smoking: A report of the Surgeon General. Washington DC, USHS Publication No. CDC 87-8398, 1986.
31. National Research Council: Environmental tobacco smoke: Measuring exposures and assessing health effects. Washington DC, National Academy, 1986.
32. Wald N., Nanchahal K., Thompson S. Does breathing other people's tobacco smoke cause lung cancer? Br. J. Med. 293:1986;1712-1722.
33. Spitzer W.O., Lawrence V., Dales R. et al. Links between smoking and disease: a best evidence synthesis: a report of the working group on passive smoking. Clin. Invest. Med. 13:1990;17-42.
34. Cardenas V.M., Thun M.J., Austin H. et al. Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's cancer prevention study II. Cancer Causes Control. 8:1997;57-64.
35. US Dept of Health and Human Services, Environmental Protection Agency. Respiratory health effects of passive smoking: Lung cancer and other disorders. Smoking and Tobacco Control Monograph 1993;4:93-3605.
36. Murray C.J.L., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 349:1997;1269-1276.
37. Cole P., Rodu B. Declining cancer mortality in the United States. Cancer. 78:1996;2045-2048.
38. Levi F., La Vecchia C., Lucchini F. Cancer mortality in Europe, 1990-92. Euro. J. Cancer Prev. 4:1995;389-417.
39. Risser N.L. Prevention of lung cancer: the key is to stop smoking. Semin. Oncol. Nurs. 12:1996;260-269.
40. Koh H. An analysis of the successful 1992 Massachusetts tobacco tax initiative. Tobacco Control. 5:1996;220-225.
41. Lupulescu A.P. Hormones, vitamins, and growth factors in cancer treatment and prevention: a critical appraisal. Cancer. 78:1996;2264-2280.
42. Estensen R.D., Wattenberg L.W. Studies of chemopreventive effects of myo-inositol on benzo[a]-pyrene-induced neoplasia of the lung and forestomach of female A/J mice. Carcinogenesis. 14:1993;1975-1977.
43. Wattenberg L.W., Estensen R.D. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrne and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res. 56:1996;5132-5135.
44. Castonguay A., Rioux N. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols. Carcinogenesis. 18:1997;491-496.
45. Spitz M.R., Bondy M.L. Genetic susceptibility to cancer. Cancer. 72 (Suppl):1993;991-995.
46. Mooney L.A., Perera F.P. Application of molecular epidemiology to lung cancer chemoprevention. J. Cell. Biochem. 255:1996;63-68.
47. McWilliams J.E., Sandeerson B.J.S., Harris E.L. et al. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomark. Prev. 4:1995;589-594.
48. Nelson H.H., Wiencke J., Christiani D.C. et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 16:1995;1243-1245.
49. Melamed M.R., Zaman M.B., Flehinger B.H. et al. Radiologically occult in situ and incipient invasive epidemiod lung cancer: detection by sputum cytology in a survey of asymptomatic cigarette smokers. Am. J. Surg. Pathol. 1:1977;5.
50. Topping D.C., Griesemer R.A., Nettesheim P. Quantitative assessment of generalized epithelial changes in tracheal mucosa following exposure to 7,12-dimethylbenz(a)anthracene. Cancer Res. 39:1979;4823.
51. Ono J., Auer G., Caspersson T. et al. Reversibility of 20-methyl-cholanthrene-induced bronchial cell atypia in dogs. Cancer. 54:1984;1030.
52. Mao L., Hruban R.H., Boyle J.O. et al. Detection of oncogen mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 54:1994;1634-1637.
53. Mao L., Lee J.S., Kurie J.M. et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89:1997;857-862.
54. Isobe M., Emanuel B.S., Givol D. et al. Localisation of gene for human p53 tumour antigen to band 17p13. Nature. 320:1986;84-85.
55. Ohta M., Inoue H., Cotticelli M.G. et al. The FHIT gene, spanding the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:1996;587-597.
56. Kamb A., Gruis N.A., Weaver-Feldhaus J. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
57. Nobori T., Muira K., Wu D. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers'. Nature. 368:1994;753-756.
58. Kelloff G.J., Hawk E.T., Karp J.E. et al. Progress in clinical chemoprevention. Semin. Oncol. 24:1997;241-252.
59. Bollag W., Hartmann H.R. Prevention and therapy of cancer with retinoids in animals and man. Cancer Surv. 2:1983;293-314.
60. Lippman S.M., Benner S.E., Hong W.K. Cancer chemoprevention. J. Clin. Oncol. 12:1994;851-873.
61. Omenn G.S., Goodman G.E., Thornquist M.D. et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med. 334:1996;1150-1155.
62. Pastorino U., Infante M., Maioli M. et al. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J. Clin. Oncol. 11:1993;1216-1222.
63. Hong W.K., Lippman S.M., Itri L.M. et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New Engl. J. Med. 323:1990;95-801.
64. Thomas P., Rubinstein L. Lung cancer study group: cancer recurrence after resecion: T1N0 non-small cell lung cancer. Ann. Thorac. Surg. 49:1990;242.
65. van Zandwijk N., Pastorino U., de Vries N. et al. EUROSCAN: the European Organization for Research and Treatment of Cancer (EORTC): chemoprevention study in lung cancer. Lung Cancer. 9:1993;351-356.
66. Lee J.S., Lippman S.M., Benner S.E. et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J. Clin. Oncol. 12:1994;937-945.
67. Costa A., Formelli F., Chiesa F. et al. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. 54:1994;203A-2037S.
68. Greenwald P. NCI cancer prevention and control research. Prev. Med. 22:1993;642-660.
69. Ziegler R.G. A review of the epidemiologic evidence that carotenoids reduce the risk of cancer. J. Nutr. 119:1989;116-122.
70. Byers T. Diet as a factor in the etiology and prevention of lung cancer. Samet J.M. Epidemiology of Lung Cancer. 1994;335-352 Marcel Dekker, New York.
71. Willett W.C., Polk B.F., Underwood B.A. et al. Relation of serum vitamins A and E and carotenoids to the risk of cancer. New Engl. J. Med. 310:1984;430-434.
72. Nomura A.M.Y., Stemmermann G.N., Heilbrun L.K. et al. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res. 45:1985;2369-2372.
73. Menkes M.S., Comstock G.W., Vuilleumier J.P. et al. Serum beta-carotene, vitamns A and E, selenium, and the risk of lung cancer. New Engl. J. Med. 315:1986;1250-1254.
74. Peto R., Doll R., Buckley J.D., Sporn M.B. Can dietary b-carotene materially reduce human cancer rates? Nature. 290:1981;201-209.
75. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med. 330:1029-35, 1994.
76. Omenn G.S., Goodman G., Thornquist M. et al. The b-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res. 54:1994;2038s-2043s.
77. Omenn G., Goodman G., Thornquist M. et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J. Natl. Cancer Inst. 88:1996;1550-1559.
78. Albanes D., Heinonen O.P., Taylor P.R. et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-topcopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88:1996;1560-1570.
79. Ziegler R.G., Colavito E.A., Hartge P. et al. Importance of alpha-carotene, beta-carotene, and other phytochemicals in the etiology of lung cancer. J. Natl. Cancer Inst. 88:1996;612-615.
80. Stahl W., Sies H. Perspectives in biochemistry and biophysics; lycopene: a biologically important carotenoid for humans? Arch. Biochem. Biophys. 336:1996;1-9.
81. Clinton S.K., Emenhiser C., Schwartz S.J. et al. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol. Biol. Prev. 5:1996;823-833.
82. Ziegler R.G., Mayne S.T., Swanson C.A. Nutrition and lung cancer. Cancer Causes Control. 7:1996;157-177.
83. Ocke M.C., De-Mesquita B.B., Feskens E.J.M. et al. Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer. Am. J. Epidemiol. 145:1997;358-365.
84. Knekt P., Jarvinen R., Seppanen R. et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 146:1997;223-230.
85. Hecht S.S. Chemoprevention of lung cancer by isothiocyanates. Adv Exp Med Biol. 401:1996;1-11.
86. Stoner G.D., Morse M.A. Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett. 114:1997;113-119.
87. van den Brandt P.A., Goldbohm R.A., van't Veer P. et al. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res. 53:1993;4860-4865.
88. Clark L.C., Combs G.F., Turnbull B.W. et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J. Am. Med. Assoc. 276:1996;1957-1963.